Michael D Huband (M D Huband, Michael Huband)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Multidrug Resistant

Candida Albicans

Quality Control

Cystic Fibrosis

Top Venues

Antimicrobial agents and chemotherapy

Journal of clinical microbiology

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Pfaller, Michael D Huband, Paul A Bien, Cecilia Godoy Carvalhaes, Abby Klauer, Mariana Castanheira
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022). Antimicrobial agents and chemotherapy (2024)
Michael Pfaller, Michael D Huband, Paul A Bien, Cecilia Godoy Carvalhaes, Abby Klauer, Mariana Castanheira
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022). Antimicrobial agents and chemotherapy 68 (2) (2024)
Michael Pfaller, Michael D Huband, Paul A Bien, Cecilia Godoy Carvalhaes, Abby Klauer, Mariana Castanheira
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022). Antimicrobial agents and chemotherapy 68 (2) (2024)
Michael Pfaller, Michael D Huband, Paul A Bien, Cecilia Godoy Carvalhaes, Abby Klauer, Mariana Castanheira
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022). Antimicrobial agents and chemotherapy 68 (2) (2024)
Sarah M McLeod, Nicole M Carter, Michael D Huband, Maria M Traczewski, Patricia A Bradford, Alita A Miller
Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests. Journal of clinical microbiology (2023)
Michael D Huband, Kelley A Fedler, Helio Silva Sader, Gregory G Stone, Mariana Castanheira
Determination of MIC Quality Control Ranges for Ceftibuten-Avibactam (Fixed 4 μg/mL), a Novel β-Lactam/β-Lactamase Inhibitor Combination. Journal of clinical microbiology (2023)
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, Michael Trang, Justin C Bader, Catharine C Bulik, Brian D VanScoy, Christopher M Rubino, Michael D Huband, Lawrence Friedrich, Judith N Steenbergen, Paul G Ambrose
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae. Antimicrobial agents and chemotherapy (2023)
M A Pfaller, Michael D Huband, P R Rhomberg, P A Bien, Mariana Castanheira
Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020). Antimicrobial agents and chemotherapy 66 (11) (2022)
Helio Silva Sader, Mariana Castanheira, Michael D Huband, Dee Shortridge, Cecilia Godoy Carvalhaes, Rodrigo Elisandro Mendes
Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018-2020). European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 41 (5) (2022)
Michael D Huband, Jennifer D Thompson, Nabina D Gurung, Qingmei Liu, Li Li, Jay Zhang, Jennifer M Streit, Mariana Castanheira
Activity of KBP-7072 (a novel aminomethylcycline) and comparators against 1,057 geographically diverse recent clinical isolates from the SENTRY Surveillace Program (2019). Antimicrobial agents and chemotherapy (2021)